St. John's wort for the treatment of psychiatric disorders
Copyright © 2013 Elsevier Inc. All rights reserved..
St. John's wort (Hypericum perforatum) has been extensively studied and reviewed for its use in depression; however, there is less salient discussion on its clinical application for a range of other psychiatric disorders. This article outlines the current evidence of the efficacy of St John's wort in common psychiatric disorders, including major depression, bipolar depression, attention-deficit hyperactivity disorder, obsessive-compulsive disorder, social phobia, and somatization disorder. Mechanisms of action, including emerging pharmacogenetic data, safety, and clinical considerations are also detailed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2013 |
---|---|
Erschienen: |
2013 |
Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
---|---|
Enthalten in: |
The Psychiatric clinics of North America - 36(2013), 1 vom: 01. März, Seite 65-72 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sarris, Jerome [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 16.12.2013 Date Revised 29.03.2013 published: Print Citation Status MEDLINE |
---|
doi: |
10.1016/j.psc.2013.01.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM226217841 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM226217841 | ||
003 | DE-627 | ||
005 | 20231224070936.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.psc.2013.01.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n0754.xml |
035 | |a (DE-627)NLM226217841 | ||
035 | |a (NLM)23538077 | ||
035 | |a (PII)S0193-953X(13)00005-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sarris, Jerome |e verfasserin |4 aut | |
245 | 1 | 0 | |a St. John's wort for the treatment of psychiatric disorders |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.12.2013 | ||
500 | |a Date Revised 29.03.2013 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2013 Elsevier Inc. All rights reserved. | ||
520 | |a St. John's wort (Hypericum perforatum) has been extensively studied and reviewed for its use in depression; however, there is less salient discussion on its clinical application for a range of other psychiatric disorders. This article outlines the current evidence of the efficacy of St John's wort in common psychiatric disorders, including major depression, bipolar depression, attention-deficit hyperactivity disorder, obsessive-compulsive disorder, social phobia, and somatization disorder. Mechanisms of action, including emerging pharmacogenetic data, safety, and clinical considerations are also detailed | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Plant Extracts |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t The Psychiatric clinics of North America |d 1984 |g 36(2013), 1 vom: 01. März, Seite 65-72 |w (DE-627)NLM013292390 |x 1558-3147 |7 nnns |
773 | 1 | 8 | |g volume:36 |g year:2013 |g number:1 |g day:01 |g month:03 |g pages:65-72 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.psc.2013.01.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 36 |j 2013 |e 1 |b 01 |c 03 |h 65-72 |